BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15488171)

  • 1. RGS2-mediated regulation of Gqalpha.
    Heximer SP
    Methods Enzymol; 2004; 390():65-82. PubMed ID: 15488171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell imaging of intracellular Ca2+ and phospholipase C activity reveals that RGS 2, 3, and 4 differentially regulate signaling via the Galphaq/11-linked muscarinic M3 receptor.
    Tovey SC; Willars GB
    Mol Pharmacol; 2004 Dec; 66(6):1453-64. PubMed ID: 15383626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of receptor-selective effects of either RGS2, RGS3 or RGS4 on muscarinic M3- and gonadotropin-releasing hormone receptor-mediated signalling through G alpha q/11.
    Karakoula A; Tovey SC; Brighton PJ; Willars GB
    Eur J Pharmacol; 2008 Jun; 587(1-3):16-24. PubMed ID: 18457830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmitoylation and its effect on the GTPase-activating activity and conformation of RGS2.
    Ni J; Qu L; Yang H; Wang M; Huang Y
    Int J Biochem Cell Biol; 2006; 38(12):2209-18. PubMed ID: 16945566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel regulator of G protein signalling in yeast, Rgs2, downregulates glucose-activation of the cAMP pathway through direct inhibition of Gpa2.
    Versele M; de Winde JH; Thevelein JM
    EMBO J; 1999 Oct; 18(20):5577-91. PubMed ID: 10523302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RGS2 gene product from a candidate hypertension allele shows decreased plasma membrane association and inhibition of Gq.
    Gu S; Tirgari S; Heximer SP
    Mol Pharmacol; 2008 Apr; 73(4):1037-43. PubMed ID: 18230714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of RGS box proteins to evaluate G-protein selectivity in receptor-promoted signaling.
    Hains MD; Siderovski DP; Harden TK
    Methods Enzymol; 2004; 389():71-88. PubMed ID: 15313560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric regulation of GAP activity by phospholipids in regulators of G-protein signaling.
    Tu Y; Wilkie TM
    Methods Enzymol; 2004; 389():89-105. PubMed ID: 15313561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGS proteins: Swiss army knives in seven-transmembrane domain receptor signaling networks.
    Heximer SP; Blumer KJ
    Sci STKE; 2007 Jan; 2007(370):pe2. PubMed ID: 17244887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuning cardiomyocyte Gq signaling with RGS2.
    Muslin AJ
    J Mol Cell Cardiol; 2006 Jul; 41(1):14-6. PubMed ID: 16730746
    [No Abstract]   [Full Text] [Related]  

  • 11. Modeled structure of the whole regulator G-protein signaling-2.
    Tikhonova IG; Boulègue C; Langer I; Fourmy D
    Biochem Biophys Res Commun; 2006 Mar; 341(3):715-20. PubMed ID: 16434022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative splicing of RGS8 gene determines inhibitory function of receptor type-specific Gq signaling.
    Saitoh O; Murata Y; Odagiri M; Itoh M; Itoh H; Misaka T; Kubo Y
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10138-43. PubMed ID: 12110731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-protein signaling through tubby proteins.
    Santagata S; Boggon TJ; Baird CL; Gomez CA; Zhao J; Shan WS; Myszka DG; Shapiro L
    Science; 2001 Jun; 292(5524):2041-50. PubMed ID: 11375483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cardiomyocyte signaling by RGS proteins: differential selectivity towards G proteins and susceptibility to regulation.
    Hao J; Michalek C; Zhang W; Zhu M; Xu X; Mende U
    J Mol Cell Cardiol; 2006 Jul; 41(1):51-61. PubMed ID: 16756988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells.
    Li Y; Hashim S; Anand-Srivastava MB
    Cardiovasc Res; 2005 Jun; 66(3):503-11. PubMed ID: 15914115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent and selective inhibition of angiotensin AT1 receptor signaling by RGS2: roles of its N-terminal domain.
    Matsuzaki N; Nishiyama M; Song D; Moroi K; Kimura S
    Cell Signal; 2011 Jun; 23(6):1041-9. PubMed ID: 21291998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells.
    Bodenstein J; Sunahara RK; Neubig RR
    Mol Pharmacol; 2007 Apr; 71(4):1040-50. PubMed ID: 17220356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a direct and functional interaction between the regulators of G protein signaling-2 and phosphorylated C terminus of cholecystokinin-2 receptor.
    Langer I; Tikhonova IG; Boulègue C; Estève JP; Vatinel S; Ferrand A; Moroder L; Robberecht P; Fourmy D
    Mol Pharmacol; 2009 Mar; 75(3):502-13. PubMed ID: 19064631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence-based assays for RGS box function.
    Willard FS; Kimple RJ; Kimple AJ; Johnston CA; Siderovski DP
    Methods Enzymol; 2004; 389():56-71. PubMed ID: 15313559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells.
    Cao X; Qin J; Xie Y; Khan O; Dowd F; Scofield M; Lin MF; Tu Y
    Oncogene; 2006 Jun; 25(26):3719-34. PubMed ID: 16449965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.